Determinants of Patient Delay in Doctor Consultation in Oeso-gastric Cancers
NCT03246516 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 258
Last updated 2025-12-23
Summary
This study evaluates the role of socioeconomic and individual factors in the onset of the first symptoms of cancer and the first consultation with a doctor (patient delay) in oeso-gastric cancer.
Conditions
- Oesophageal Carcinoma
- Gastric Adenocarcinoma
Interventions
- OTHER
-
Questionnaire
Auto and hetero questionnaires: * STAI Y B, State-Trait Anxiety Inventoriage * Brief COPE * RHHI-24, Revised Health Hardiness Inventory * IPQ-R, Illness Perception Questionnaire
Sponsors & Collaborators
-
University of Lille Nord de France
collaborator OTHER -
University Hospital, Lille
lead OTHER
Principal Investigators
-
Guillaume Piessen, MD, PhD · University Hospital, Lille
Study Design
- Allocation
- NA
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-02-01
- Primary Completion
- 2025-02-07
- Completion
- 2025-02-07
Countries
- France
Study Locations
More Related Trials
-
The Relationship Between Microsatellite Instability and Efficacy of Fluorouracil Based Adjuvant Chemotherapy in Gastric Cancer After Operation
NCT03485196 ·Status: COMPLETED
-
Evidence Based Information Provision to Improve Decision Making After Oesophagogastric Cancer Diagnosis (SOURCE)
NCT04232735 ·Status: UNKNOWN ·Phase: NA
-
Preoperative Chemoradiotherapy for Locally Advanced Resectable Gastric Adenocarcinoma
NCT03814759 ·Status: COMPLETED ·Phase: PHASE2
-
NESC: Neoadjuvant Treatment of Gastric Adenocarcinoma
NCT01565109 ·Status: COMPLETED ·Phase: PHASE2
-
Prognostic and Predictive Impact of Circulating Tumor DNA in Gastric Cancer Treatment
NCT02674373 ·Status: UNKNOWN
-
Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma
NCT00515411 ·Status: COMPLETED ·Phase: PHASE2
-
Compare Different Response Evaluations to Neoadjuvant Chemotherapy for Gastric Cancer
NCT02179463 ·Status: UNKNOWN
-
Prospective Evaluation and Molecular Profiling in People With Gastric Tumors
NCT03027427 ·Status: COMPLETED
-
Docetaxel Versus Docetaxel Plus Cisplatin Versus Docetaxel Plus S-1 as Second-line Chemotherapy in Metastatic Gastric Cancer
NCT00980603 ·Status: UNKNOWN ·Phase: PHASE2
-
Postoperative Chemoradiotherapy With S-1 in Gastric Cancer
NCT01824004 ·Status: COMPLETED ·Phase: PHASE2
-
Oral Chemotherapy and Quality of Care
NCT03561467 ·Status: UNKNOWN
-
Neoadjuvant Combination Chemotherapy of DCS and DCF in Patients With Locally Advanced Gastric Adenocarcinoma
NCT01286766 ·Status: COMPLETED ·Phase: PHASE2
-
S-1, Cisplatin-based Chemoradiotherapy, Induction Chemotherapy, Locally Advanced Gastric Adenocarcinoma
NCT02495493 ·Status: COMPLETED ·Phase: PHASE2
-
Docetaxel + Oxaliplatin + S-1 in Potentially Operable Gastric or Gastroesophageal Adenocarcinoma
NCT00816543 ·Status: COMPLETED ·Phase: PHASE2
-
Induction Chemotherapy, Chemoradiotherapy and Surgery in Locally Advanced Gastric Cancer Patients
NCT02454647 ·Status: COMPLETED
-
Weekly Docetaxel Plus Cisplatin or Oxaliplatin for AGC
NCT00510107 ·Status: UNKNOWN ·Phase: PHASE2
-
Predictive Factors of Morbidity and Mortality and Overall Survival of Patients With Gastric Cancer : a Case Series
NCT05186402 ·Status: COMPLETED
-
Doxorubicin, Cisplatin, 5-Fluorouracil in Patients With Advanced Adenocarcinoma of the Stomach or Esophagus
NCT00165191 ·Status: COMPLETED ·Phase: PHASE2
-
Comparing the Prognosis of Patients With Cardia and Non-cardia Gastric Cancer.
NCT03895008 ·Status: UNKNOWN
-
Randomized Multicenter Study Comparing Docetaxel Plus Cisplatin and 5-FU to Cisplatin Plus 5-FU in Advanced Gastric Cancer
NCT00290966 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Identification of Biomarkers for Prediction of Response or Resistance Against Target Therapy in Gastric Cancer
NCT02305043 ·Status: COMPLETED
-
A Study of Raltitrexed Plus Docetaxel Versus Docetaxel as Second-line Chemotherapy in Subjects With Gastric Cancer
NCT01836120 ·Status: UNKNOWN ·Phase: PHASE2
-
Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal Junction (GEJ) Tumors
NCT00515216 ·Status: COMPLETED ·Phase: PHASE2
-
Dose-dense Biweekly Docetaxel Combined With 5-fluorouracil as First-line Treatment in Advanced Gastric Cancer
NCT01567618 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 2 Study of Neoadjuvant Docetaxel, Oxaliplatin, S-1 in Patients With Unresectable Locally Advanced or Distant Metastasis Limited to Lymph Node Gastric Cancer
NCT05184803 ·Status: RECRUITING ·Phase: PHASE2